Advertisement

Topics

Sequenom Company Profile

17:01 EST 22nd November 2017 | BioPortfolio

SEQUENOM is committed to providing the best genetic analysis products that translate genomic science into superior solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research, and potentially, clinical utility. The Company's proprietary MassARRAY® system is a high-performance DNA analysis platform that efficiently and precisely measures the amount of genetic target material and variations therein. The system is able to deliver reliable and specific data from complex biological samples and from genetic target material that is only available in trace amounts. The Company has exclusively licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY® system and other platforms.

Location

3595 John Hopkins Court
San Diego
CA
92121
United States of America

Contact

Phone: (858) 202-9000
Fax: 858 350 0344


News Articles [11 Associated News Articles listed on BioPortfolio]

Comparing Sequenom

Sequenom and Myriad Genetics are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, ri...

Law Professors File Amicus Brief Supporting En Banc Rehearing of Ariosa v. Sequenom

A group of 23 law professors, myself included, have filed an amicus brief in support of en banc rehearing of Ariosa v. Sequenom. The brief is available here.Adam Mossoff, a professor at George Ma...

Sequenom, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 11062017] Prices from USD $350

Sequenom, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sequenom, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report inclu...

WARF Files Amicus Brief in Support of En Banc Rehearing of Ariosa v. Sequenom

The Federal Circuit’s discouraging opinion in Ariosa v. Sequenom has been discussed in previous posts.  Sequenom has petitioned for en banc rehearing, its brief is available here, Amicus brief...

Sequenom Obtains Patent: "Bead Linkers for Immobilizing Nucleic Acids to Solid Supports"

The US Patent and Trademark Office has granted Sequenom Inc. (San Diego) a key patent entitled "Bead Linkers for Immobilizing Nucleic Acids to Solid Supports" (no. 5,900,481)...

Sequenom Petitions Supreme Court for Review of Ariosa Decision

Sequenom today filed a Petition for Writ of Certiorari asking the Supreme Court to review Ariosa Diagnostics v. Sequenom, an important patent eligibility case described in previous posts (see for exa...

Here Are All the Amicus Briefs That Have Been Filed Seeking En Banc Rehearing of Ariosa v. Sequenom

Yesterday I posted the amici brief I filed on behalf of BIO and PhRMA seeking en banc rehearing of Ariosa v. Sequenom.  Here are links to all twelve amicus briefs that were filed, in one place f...

PTV News: Sep 29, 2009

Top stories on September 29th, 2009: Sacked - Sequenom's top management team goes after trials mishandled GSK's innovative US$2.2B vaccine deal with Brazil Atacicept fails again Avastin's hea...

Drugs and Medications [0 Results]

None

PubMed Articles [13 Associated PubMed Articles listed on BioPortfolio]

DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.

MicroRNA-874 (miR-874) is downregulated in several human cancers and has been suggested to be a tumor suppressor gene. However, the molecular mechanism of miR-874 downregulation in breast cancer has n...

Filaggrin gene polymorphism associated with Epstein-Barr virus-associated tumors in China.

Mutations of filaggrin gene (FLG) have been identified as the cause of ichthyosis vulgaris, while recently FLG mutations were found to be associated with gastric cancer. This study aimed to investigat...

Association between regulator of telomere elongation helicase1 (RTEL1) gene and HAPE risk: A case-control study.

High altitude pulmonary edema (HAPE) is a paradigm of pulmonary edema. Mutations in regulator of telomere elongation helicase1 (RTEL1) represent an important contributor to risk for pulmonary fibrosis...

The association between genetic variation in interleukin-10 gene and susceptibility to Henoch-Schönlein purpura in Chinese children.

Interleukin-10 (IL-10), one of the anti-inflammatory cytokines, plays a major role in the pathogenesis of Henoch-Schönlein purpura (HSP). In present study, we investigated the association between gen...

Association between single nucleotide polymorphisms in AKT1 and the risk of prostate cancer in the Chinese Han population.

AKT1, also known as v-akt murine thymoma viral oncogene homolog 1, is involved in the regulation of cell-survival and anti-apoptotic activities, which may affect the pathogenesis of various cancers. H...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) is not a single disease, but a composite of heterogeneous subgroup. Accordingly, more sophisticated classification in ALL is essential to achieve further...

Companies [4 Associated Companies listed on BioPortfolio]

Sequenom, Inc.

Sequenom, Inc. (Nasdaq: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagn...

Sequenom

SEQUENOM is committed to providing the best genetic analysis products that translate genomic science into superior solutions for biomedical research, agricultural applications, molecular medicine and ...

Bionest Partners Inc.

Bionest Partners Inc. provides strategy consulting services exclusively for the life science industries to help pharmaceutical, biopharmaceutical, diagnostics, biotechnology, and ...

NewGene Limited

The demand for testing individuals for genetic disorders or cancers that have arisen from acquired genetic variations is growing year on year.  This is being driven by advances in medical genet...

More Information about "Sequenom" on BioPortfolio

We have published hundreds of Sequenom news stories on BioPortfolio along with dozens of Sequenom Clinical Trials and PubMed Articles about Sequenom for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sequenom Companies in our database. You can also find out about relevant Sequenom Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record